Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy.
- DOI
- 10.1093/hmg/ddz064
- Published
- 2019 Jul 15
- Container
- Human molecular genetics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/hmg/ddz064,
title = {Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy.},
author = {Saha M and Rizzo SA and Ramanathan M and Hightower RM and Santostefano KE and Terada N and Finkel RS and Berg JS and Chahin N and Pacak CA and Wagner RE and Alexander MS and Draper I and Kang PB},
year = {2019},
journal = {Human molecular genetics},
doi = {10.1093/hmg/ddz064},
url = {https://doi.org/10.1093/hmg/ddz064}
}RIS
TY - JOUR TI - Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy. AU - Saha M AU - Rizzo SA AU - Ramanathan M AU - Hightower RM AU - Santostefano KE AU - Terada N AU - Finkel RS AU - Berg JS AU - Chahin N AU - Pacak CA AU - Wagner RE AU - Alexander MS AU - Draper I AU - Kang PB PY - 2019 JO - Human molecular genetics DO - 10.1093/hmg/ddz064 UR - https://doi.org/10.1093/hmg/ddz064 ER -
APA
M, S., SA, R., M, R., RM, H., KE, S., N, T., RS, F., JS, B., N, C., CA, P., RE, W., MS, A., I, D., & PB, K. (2019). Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathy.. Human molecular genetics. https://doi.org/10.1093/hmg/ddz064
Source records
- pubmed · retrieved 2026-09-26T22:55:36.806Z